Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added results metrics (pathologic complete response rate, overall survival, disease-free survival) and counts of drug-related toxicities with posting dates; included investigator/site details (Arsen Osipov, MD; Cedars-Sinai; The University of Texas Health Science Center at San Antonio) and attached the Study Protocol and Statistical Analysis Plan document.
    Difference
    3%
    Check dated 2026-02-11T01:46:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice about data currency and NIH operations was added, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:43:18.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The updates are minor UI and metadata updates (glossary toggle, capitalization tweaks, and version notes) that do not affect study details or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:27:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision note was updated from v3.3.3 to v3.3.4, a minor metadata change with no impact on core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:24:34.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing California, Maryland, and Texas (replacing the former state-specific location subsections) and updated the page to revision v3.3.3; the HHS Vulnerability Disclosure link was removed.
    Difference
    0.5%
    Check dated 2025-12-23T13:39:02.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page now displays 'Results Submitted' instead of 'No Results Posted', indicating that study results have been submitted.
    Difference
    0.1%
    Check dated 2025-12-09T00:58:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.